Literature DB >> 8183428

Convulsions and inhibition of glutamate decarboxylase by pyridoxal phosphate-gamma-glutamyl hydrazone in the developing rat.

L Massieu1, A Rivera, R Tapia.   

Abstract

We have previously shown that in the adult rat the inhibition of brain glutamate decarboxylase (GAD) activity by pyridoxal phosphate-gamma-glutamyl hydrazone (PLPGH) administration does not result in convulsions, whereas in the adult mouse intense convulsions invariably occur. In the present study we report that, surprisingly, immature rats from 2 to 20 days of age treated with PLPGH (80 mg/kg) showed generalized tonic-clonic convulsions, whereas no convulsions at all were present in 30 days-old or older rats. GAD activity, measured by enzymic determination of GABA formed in forebrain homogenates, was inhibited by about 60% at the time of convulsions in 15 days-old and younger rats, whereas the inhibition was between 40 and 50% in older animals. The addition of the coenzyme pyridoxal 5'-phosphate to the incubation medium completely reversed this inhibition. In all treated animals GABA levels were lower compared to controls. The results indicate that the susceptibility of GAD in vivo to a diminished cofactor concentration decreases with age. It seems possible that changes in the expression of enzyme forms are reflected in developmental variations in the susceptibility to seizures induced by vitamin B6 depletion, but alterations of other B6-dependent biochemical pathways cannot be discarded.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8183428     DOI: 10.1007/bf00966814

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  Developmentally regulated expression of an exon containing a stop codon in the gene for glutamic acid decarboxylase.

Authors:  R W Bond; R J Wyborski; D I Gottlieb
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 2.  Epilepsy and gamma-aminobutyric acid-mediated inhibition.

Authors:  B S Meldrum
Journal:  Int Rev Neurobiol       Date:  1975       Impact factor: 3.230

Review 3.  The structural and functional heterogeneity of glutamic acid decarboxylase: a review.

Authors:  M G Erlander; A J Tobin
Journal:  Neurochem Res       Date:  1991-03       Impact factor: 3.996

4.  Kinetics of brain glutamate decarboxylase. Inhibition studies with N-(5'-phosphopyridoxyl) amino acids.

Authors:  A Bayón; L D Possani; R Tapia
Journal:  J Neurochem       Date:  1977-09       Impact factor: 5.372

5.  Pyridoxal phosphate and glutamate decarboxylase in subcellular particles of mouse brain and their relationship to convulsions.

Authors:  M Pérez de la Mora; A Feria-Velasco; R Tapia
Journal:  J Neurochem       Date:  1973-06       Impact factor: 5.372

6.  Some effects of dietary vitamin B 6 deficiency on -aminobutyric acid metabolism in developing rat brain.

Authors:  R A Bayoumi; W R Smith
Journal:  J Neurochem       Date:  1972-08       Impact factor: 5.372

7.  Effects of various substituted hydrazones and hydrazines of pyridoxal-5'-phosphate on brain glutamate decarboxylase.

Authors:  R Tapia; J Awapara
Journal:  Biochem Pharmacol       Date:  1969-01       Impact factor: 5.858

8.  Release of acetylcholine, gamma-aminobutyrate, dopamine and glutamate, and activity of some related enzymes, in rat gustatory neocortex.

Authors:  J C López-García; F Bermúdez-Rattoni; R Tapia
Journal:  Brain Res       Date:  1990-07-16       Impact factor: 3.252

9.  Glutamate decarboxylase inhibition and vitamin B6 metabolism in brain of cirrhotic rats chronically treated with carbon tetrachloride.

Authors:  M Díaz-Muñoz; R Tapia
Journal:  J Neurosci Res       Date:  1988-07       Impact factor: 4.164

10.  Kynurenines and seizures.

Authors:  I P Lapin
Journal:  Epilepsia       Date:  1981-06       Impact factor: 5.864

View more
  2 in total

Review 1.  GABA effects during neuronal differentiation of stem cells.

Authors:  Patricia Salazar; Marco A Velasco-Velázquez; Iván Velasco
Journal:  Neurochem Res       Date:  2008-03-21       Impact factor: 3.996

2.  Impaired PLP-dependent metabolism in brain samples from Huntington disease patients and transgenic R6/1 mice.

Authors:  M Alba Sorolla; María José Rodríguez-Colman; Núria Vall-Llaura; Celia Vived; Marta Fernández-Nogales; José J Lucas; Isidre Ferrer; Elisa Cabiscol
Journal:  Metab Brain Dis       Date:  2015-12-14       Impact factor: 3.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.